Middeldorp S - Search Results

1

Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.

Hokusai-VTE Investigators; Büller HR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, Raskob GE, Schellong SM, Schwocho L, Segers A, Shi M, Verhamme P, Wells P. Hokusai-VTE Investigators, et al. Among authors: middeldorp s. N Engl J Med. 2013 Oct 10;369(15):1406-15. doi: 10.1056/NEJMoa1306638. Epub 2013 Aug 31. N Engl J Med. 2013. PMID: 23991658 Free article. Clinical Trial.

2

The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.

Middeldorp S, Henkens CM, Koopman MM, van Pampus EC, Hamulyák K, van der Meer J, Prins MH, Büller HR. Middeldorp S, et al. Ann Intern Med. 1998 Jan 1;128(1):15-20. doi: 10.7326/0003-4819-128-1-199801010-00003. Ann Intern Med. 1998. PMID: 9424976

3

Oral contraceptives and hormonal replacement therapy cause an imbalance in coagulation and fibrinolysis which may explain the increased risk of venous thromboembolism.

Levi M, Middeldorp S, Büller HR. Levi M, et al. Among authors: middeldorp s. Cardiovasc Res. 1999 Jan;41(1):21-4. doi: 10.1016/s0008-6363(98)00210-7. Cardiovasc Res. 1999. PMID: 10325950 No abstract available.

4

Increased risk for fetal loss in carriers of the factor V Leiden mutation.

Meinardi JR, Middeldorp S, de Kam PJ, Koopman MM, van Pampus EC, Hamulyák K, Prins MH, Büller HR, van der Meer J. Meinardi JR, et al. Among authors: middeldorp s. Ann Intern Med. 1999 May 4;130(9):736-9. doi: 10.7326/0003-4819-130-9-199905040-00013. Ann Intern Med. 1999. PMID: 10357692

5

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.

Rosing J, Middeldorp S, Curvers J, Christella M, Thomassen LG, Nicolaes GA, Meijers JC, Bouma BN, Büller HR, Prins MH, Tans G. Rosing J, et al. Among authors: middeldorp s. Lancet. 1999 Dec 11;354(9195):2036-40. doi: 10.1016/s0140-6736(99)06092-4. Lancet. 1999. PMID: 10636369 Clinical Trial.

6

Monitoring therapy with vitamin K antagonists in patients with lupus anticoagulant: effect on different tests for INR determination.

Bijsterveld NR, Middeldorp S, Berends F, Büller HR. Bijsterveld NR, et al. Among authors: middeldorp s. J Thromb Thrombolysis. 2000 Apr;9(3):263-9. doi: 10.1023/a:1018722829498. J Thromb Thrombolysis. 2000. PMID: 10728026

7

Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.

Middeldorp S, Meijers JC, van den Ende AE, van Enk A, Bouma BN, Tans G, Rosing J, Prins MH, Büller HR. Middeldorp S, et al. Thromb Haemost. 2000 Jul;84(1):4-8. Thromb Haemost. 2000. PMID: 10928461 Clinical Trial.

8

A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.

Tans G, Curvers J, Middeldorp S, Thomassen MC, Meijers JC, Prins MH, Bouma BN, Büller HR, Rosing J. Tans G, et al. Among authors: middeldorp s. Thromb Haemost. 2000 Jul;84(1):15-21. Thromb Haemost. 2000. PMID: 10928463 Clinical Trial.

9

How to decide on the optimal duration of anticoagulatn therapy in carriers of the factor V Leiden mutation.

Middeldorp S, Büller HR. Middeldorp S, et al. Thromb Haemost. 2000 Nov;84(5):740-1. Thromb Haemost. 2000. PMID: 11127847 No abstract available.

10

[Effects of second and third generation oral contraceptives on hemostasis].

Middeldorp S, Rosing J, Bouma BN, Büller HR. Middeldorp S, et al. Ned Tijdschr Geneeskd. 2001 Feb 10;145(6):252-6. Ned Tijdschr Geneeskd. 2001. PMID: 11236370 Review. Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

469 results

Search Page

Filters